The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prevalence of cytopenic myelofibrosis in the United States.
 
Lucia Masarova
Employment - MD Anderson Cancer Center
Consulting or Advisory Role - Cogent Biosciences; Pharmaessentia
Travel, Accommodations, Expenses - GlaxoSmithKline
(OPTIONAL) Uncompensated Relationships - MorphoSys
 
Lindsay Rein
Consulting or Advisory Role - Abbvie; Cogent Biosciences; Incyte; MorphoSys; Novartis; SOBI; Sumitomo
Travel, Accommodations, Expenses - Dava Oncology
 
Nicole Engel-Nitz
Employment - Optum
Stock and Other Ownership Interests - Optum
Research Funding - AstraZeneca/Daiichi Sankyo (Inst); BeiGene (Inst); Bristol-Myers Squibb (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Intuitive Surgical (Inst); Jazz Pharmaceuticals (Inst); Merck (Inst); Pfizer (Inst); Photocure (Inst); Rocket Pharma (Inst); Sandoz (Inst); SOBI (Inst); Star Therapeutics (Inst)
 
Michael Marrone
Employment - SOBI; Team Health (I)
 
Jeffrey McPheeters
Employment - Optum
 
Abiola Oladapo
Employment - Sobi
Stock and Other Ownership Interests - Biogen; Takeda
Research Funding - Sobi
Travel, Accommodations, Expenses - Sobi
Other Relationship - SOBI
 
Purvi Suthar
Employment - Sobi
Travel, Accommodations, Expenses - Sobi
Other Relationship - SOBI
 
Michael Vredenburg
Employment - Sobi
Stock and Other Ownership Interests - ETFs, no individual company
 
Yong Zhu
Employment - United Health Group
Stock and Other Ownership Interests - United Health Group
Research Funding - Alnylam (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol Myers Squibb (Inst); GlaxoSmithKline (Inst); Jazz Pharmaceuticals (Inst); Lilly (Inst); Merck (Inst); Novo Nordisk (Inst); SOBI (Inst)
 
Aaron Gerds
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb/Celgene; CTI; GlaxoSmithKline/Sierra Oncology; Imago Pharma; Kartos Therapeutics; MorphoSys; Pharmaessentia; Rain Therapeutics
Research Funding - Celgene; CTI; Gilead Sciences; Incyte; Pfizer; Roche/Genentech